The transition from moderate to compulsive alcohol drinking is driven by increasingly dysfunctional reward and stress systems. We review behavioral and pharmacological studies of alcohol self-administration in rats that were mainly conducted within the framework of the alcohol vapor model of dependence. We discuss neurotransmitter systems that are implicated in alcohol drinking, with a focus on contrasting those neurotransmitter systems that drive behavior in the dependent versus nondependent states. We hypothesize that the identification of systems that become increasingly dysfunctional in alcohol dependence will reveal possible targets for successful interventions to reduce the motivation that drives compulsive alcohol drinking. In our opinion, drugs that normalize, rather than block, a hypofunctional reward system by restoring the function of hypothalamic stress systems and desensitize extrahypothalamic stress systems have the potential to selectively and effectively curb compulsive alcohol drinking.
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Introduction
Alcohol dependence (AD) is a major public health issue, the mortality and morbidity of which affects 6% of the global population [2] . Alcohol dependence has been conceptualized as a three-stage, recurring cycle that comprises binge/intoxication, withdrawal/negative affect, and preoccupation/anticipation ('craving') stages. These stages involve neuroplastic changes in brain reward, stress, and executive function systems that are controlled by neurocircuits that involve the basal ganglia, extended amygdala, and prefrontal cortex, respectively [3] . Although medications currently exist for the treatment of AD, they are only moderately effective [4] .
In this opinion article, we argue that AD is associated with disruption of hypothalamic stress systems that contribute to brain reward hypofunction and sensitization of extrahypothalamic stress systems. We propose that these processes lead to the negative emotional states that characterize motivational withdrawal and drive compulsive alcohol drinking via negative reinforcement (i.e., alcohol is consumed to alleviate negative feelings).
Vapor model of alcohol dependence
Multiple rodent models of alcohol drinking exist. However, a major setback in the development of valid models of AD is that rodents will rarely voluntarily self-administer alcohol to the point of dependence without the use of prohibitively lengthy experimental designs. To overcome this obstacle, passive exposure to alcohol vapors has been used for over two decades to reliably create somatic signs of dependence (e.g., tail stiffness, abnormal gait/posture, and vocalization upon touch) and motivational signs of dependence (e.g., increased anxiety-like and hypohedonic-like behavior). Typically, passive daily cycles of alcohol intoxication that produce blood alcohol levels around 150-250 mg/dl and withdrawal are used in combination with voluntary, operant alcohol self-administration to measure the motivation for alcohol during alcohol withdrawal. Compared with nondependent controls that are exposed to air, vapor-exposed rodents exhibit an escalation of intake and compulsive-like drinking behavior (for review, see [5, 6] ).
In the present article, we use the vapor model as a framework to discuss central neurotransmitter systems that are involved in normal, controlled versus escalated, compulsive-like drinking. Most of the studies discussed herein tested the effects of acute drug treatments in rats on drinking during acute withdrawal (typically 2-8 hours into withdrawal). Figure 1 summarizes the dependent versus nondependent specificity of the effects of systemically and intracerebroventricularly (but not site-specific 
